Table 1 Clinicodemographic characteristics of the epilepsy group and the control group
Characteristics | Epilepsy group n = 223 | Control group n = 218 | P value |
|---|---|---|---|
Male | 101 (45.3) | 94 (43.1) | 0.701 |
Age, years | 30.59 ± 10.95 | 32.06 ± 10.71 | 0.156 |
Married | 100 (44.8) | 79 (36.2) | 0.081 |
Years of education | |||
≤ 12 | 98 (43.9) | 80 (36.7) | 0.145 |
> 12 | 125 (56.1) | ||
Monthly household income, RMB* | < 0.001 | ||
0–4999 | 154 (49.1) | 58 (26.6) | |
5000–9999 | 59 (26.5) | 78 (35.8) | |
10,000–19,999 | 8 (3.6) | 35 (16.1) | |
≥ 20,000 | 2 (0.9) | 47 (21.6) | |
History of mental illness | 12 (5.4) | 4 (1.8) | 0.072 |
Epilepsy type | |||
Generalized | 43 (19.3) | ||
Focal | 169 (75.8) | ||
Unclassified | 11 (4.9) | ||
Drug-resistant epilepsy | 51 (22.9) | ||
Total number of antiseizure medications ever taken | 2 (1,6) | ||
Tested positive for SARS-CoV-2 infection | 127 (57.0) | 174 (79.8) | < 0.001 |
Seizure onset within previous 30 days | |||
Before the outbreak | 50 (22.4) | ||
Before the second questionnaire (during the outbreak) | 66 (29.6) | ||
Kessler-6 score | |||
Before the outbreak | 5 (5, 2) | ||
Before the second questionnaire | 9 (24, 6) | 2 (24, 0) | < 0.001 |